Key Takeaways IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price increases.The veterinary healthcare company benefited from higher demand for ...

Screening milk for pregnancy-associated glycoprotein could help dairy farmers detect pregnancy earlier than traditional ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

A recent survey indicates that 73% of pet owners are interested in having a cancer screening test for their pet ... Early data shows IDEXX Cancer Dx testing can detect lymphoma before clinical ...

IDXX has unveiled the IDEXX Cancer Dx, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs. This affordable and accessible blood test can be added to panels for sick pets ...

Presentation Operator Good morning, and welcome to the IDEX Laboratories 4th-Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the ...

IDEXX Cancer Dx is an affordable and accessible blood test that can be added to panels for sick pets and integrated into annual wellness screenings for as low as $15, providing veterinarians in the US ...

Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...